vTv Therapeutics Inc. (VTVT) Ownership
VTVT ownership summary
as of October 17, 2026- Institutions
- 42.6% of shares outstanding
- Insiders
- 38.83% of shares outstanding
- Shares outstanding
- 4.0M
- Float
- 2.2M shares available to trade
- Short interest
- 6.53% 157K shares short
- Days to cover
- 3.66 short interest down 2.2% vs prior month
- Institutions 42.59%
- Insiders 38.83%
- Other investors 18.58%
VTVT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Samsara BioCapital, LLC | 7.55% | 298K | $7.9M | — | June 30, 2026 |
| 2 | Millennium Management LLC | 6.83% | 270K | $7.2M | +63,586 (+30.8%) | June 30, 2026 |
| 3 | FMR Inc | 6.59% | 260K | $6.9M | — | June 30, 2026 |
| 4 | Siren, L.L.C. | 4.12% | 163K | $4.3M | — | June 30, 2026 |
| 5 | Baker Bros Advisors LP | 3.75% | 148K | $3.9M | — | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 2.39% | 94K | $2.5M | −14,459 (−13.3%) | June 30, 2026 |
| 7 | Trails Edge Capital Partners, LP | 2.15% | 85K | $2.3M | −54,386 (−39.0%) | June 30, 2026 |
| 8 | Aisling Capital Management LP | 1.26% | 50K | $1.3M | +50,000 (0.0%) | June 30, 2026 |
| 9 | Marshall Wace Asset Management Ltd | 1.00% | 40K | $1.0M | +26,171 (+195.5%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 0.82% | 32K | $861,754 | −416 (−1.3%) | June 30, 2026 |
| 11 | Renaissance Technologies Corp | 0.44% | 17K | $463,229 | +17,454 (0.0%) | June 30, 2026 |
| 12 | Vanguard Fiduciary Trust Co | 0.41% | 16K | $430,983 | +113 (+0.7%) | June 30, 2026 |
| 13 | 683 Capital Management LLC | 0.40% | 16K | $424,640 | −2,268 (−12.4%) | March 31, 2026 |
| 14 | BlackRock Inc | 0.37% | 15K | $390,961 | +2,129 (+16.9%) | June 30, 2026 |
| 15 | Jane Street Group LLC | 0.35% | 14K | $363,678 | +13,703 (0.0%) | June 30, 2026 |
| 16 | State Street Corp | 0.31% | 12K | $325,540 | +1,600 (+15.0%) | June 30, 2026 |
| 17 | Two Sigma Investments LLC | 0.29% | 11K | $304,838 | +11,486 (0.0%) | June 30, 2026 |
| 18 | Verdad Advisers, LP | 0.23% | 8,996 | $238,754 | +8,996 (0.0%) | June 30, 2026 |
| 19 | Integrated Quantitative Investments LLC | 0.21% | 8,210 | $217,893 | +8,210 (0.0%) | June 30, 2026 |
| 20 | Susquehanna International Group, LLP | 0.20% | 8,023 | $212,930 | +8,023 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 211K shares and 4 cut 72K.
VTVT top mutual fund and ETF holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Select Biotechnology | 6.59% | 260K | $6.9M | — | August 31, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 1.54% | 61K | $1.6M | — | August 31, 2026 |
| 3 | Fidelity Extended Market Index | 0.35% | 14K | $370,206 | −75 (−0.5%) | August 31, 2026 |
| 4 | iShares Micro-Cap ETF | 0.17% | 6,898 | $183,073 | −48 (−0.7%) | September 30, 2026 |
| 5 | Fidelity Total Market Index | 0.12% | 4,775 | $126,728 | — | August 31, 2026 |
| 6 | Fidelity Series Total Market Index | 0.11% | 4,193 | $111,282 | — | August 31, 2026 |
| 7 | Invesco NASDAQ Future Gen 200 ETF | 0.09% | 3,748 | $99,472 | — | September 30, 2026 |
| 8 | China Universal Gbl YLBJ QDII CNH | 0.06% | 2,500 | $66,350 | +2,500 (0.0%) | June 30, 2026 |
| 9 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.04% | 1,523 | $40,420 | — | August 31, 2026 |
| 10 | Fidelity Nasdaq Composite Index | 0.04% | 1,405 | $37,289 | −1,119 (−44.3%) | August 31, 2026 |
| 11 | Vanguard U.S. Eq Idx £ Acc | 0.03% | 1,275 | $33,838 | — | August 31, 2026 |
| 12 | Vanguard Balanced Index Inv | 0.02% | 775 | $20,568 | — | August 31, 2026 |
| 13 | Avantis US Small Cap Equity ETF | 0.01% | 576 | $15,287 | — | September 30, 2026 |
| 14 | 1290 VT Micro Cap K | 0.01% | 486 | $12,898 | — | August 31, 2026 |
| 15 | Victory Extended Market Index | 0.01% | 236 | $6,263 | +236 (0.0%) | June 30, 2026 |
| 16 | JHVIT Total Stock Market Index I | <0.01% | 88 | $2,336 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VTVT insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-11-28 | John A Fry | Buy | $33.20 | 513 | $17,032 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VTVT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VTVT
Institutional investors own 42.6% of vTv Therapeutics's shares and insiders 38.83%. The largest holder is Samsara BioCapital, LLC with 7.55% of the shares (298K), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 4 reduced their stake in the latest filings. Short interest is 6.53% of the float, or 3.66 days of average trading volume. The share count rose 3,957.6% since 2014.
Related: VTVT analyst forecast, VTVT key metrics. See the VTVT stock overview for the latest quote and news.
VTVT ownership FAQ
Who owns the most vTv Therapeutics stock?
The largest shareholders of vTv Therapeutics are Samsara BioCapital, LLC (7.55%), Millennium Management LLC (6.83%), FMR Inc (6.59%), Siren, L.L.C. (4.12%), Baker Bros Advisors LP (3.75%).
What percentage of vTv Therapeutics is owned by institutions?
Institutions hold 42.6% of vTv Therapeutics's shares outstanding; insiders hold 38.83%.
Which funds own vTv Therapeutics?
The largest fund holders of vTv Therapeutics are Fidelity Select Biotechnology (6.59%), Vanguard MStar Total Stk Mkt Idx Invest (1.54%), Fidelity Extended Market Index (0.35%), iShares Micro-Cap ETF (0.17%), Fidelity Total Market Index (0.12%).
What is vTv Therapeutics's short interest?
157K shares of vTv Therapeutics were sold short, 6.53% of the float; at the average daily volume it would take 3.66 days to cover.
Are insiders buying or selling vTv Therapeutics?
Of the latest 1 reported insider transactions in vTv Therapeutics (since November 28, 2022), 1 were purchases and 0 were sales.
How many shares of vTv Therapeutics are outstanding?
vTv Therapeutics has 4.0M shares outstanding, of which 2.2M are in the public float.